IRIS
TONINI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 17.135
NA - Nord America 3.055
EU - Europa 1.652
OC - Oceania 56
SA - Sud America 45
AF - Africa 35
Totale 21.978
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 13.806
US - Stati Uniti d'America 2.944
HK - Hong Kong 1.871
CN - Cina 1.205
GB - Regno Unito 588
IT - Italia 360
DE - Germania 236
IN - India 112
CA - Canada 93
NL - Olanda 88
FI - Finlandia 80
AU - Australia 52
TR - Turchia 41
UA - Ucraina 38
CZ - Repubblica Ceca 36
FR - Francia 31
JP - Giappone 30
ES - Italia 29
ZA - Sudafrica 28
BR - Brasile 27
EE - Estonia 24
PL - Polonia 16
BE - Belgio 15
BG - Bulgaria 15
CH - Svizzera 15
MX - Messico 15
ID - Indonesia 14
KR - Corea 12
AT - Austria 10
SE - Svezia 10
RU - Federazione Russa 8
IL - Israele 7
LT - Lituania 7
PE - Perù 7
RO - Romania 7
TW - Taiwan 7
HU - Ungheria 6
CL - Cile 5
SA - Arabia Saudita 5
BA - Bosnia-Erzegovina 4
BD - Bangladesh 4
IE - Irlanda 4
PT - Portogallo 4
AL - Albania 3
AR - Argentina 3
BY - Bielorussia 3
EG - Egitto 3
NO - Norvegia 3
PH - Filippine 3
SI - Slovenia 3
AE - Emirati Arabi Uniti 2
FK - Isole Falkland (Malvinas) 2
GR - Grecia 2
KW - Kuwait 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
VN - Vietnam 2
AM - Armenia 1
AZ - Azerbaigian 1
BO - Bolivia 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
HR - Croazia 1
IQ - Iraq 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
MS - Montserrat 1
NG - Nigeria 1
OM - Oman 1
PS - Palestinian Territory 1
RS - Serbia 1
SL - Sierra Leone 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
TO - Tonga 1
TV - Tuvalu 1
UZ - Uzbekistan 1
YE - Yemen 1
Totale 21.978
Salva come PNG Salva come JPEG
Città #
Hong Kong 1.856
Singapore 1.114
Ashburn 809
Boardman 701
Hefei 609
London 541
Shanghai 404
San Francisco 119
Los Angeles 103
Munich 101
Pune 84
Seattle 79
Toronto 72
Council Bluffs 69
Rome 69
Washington 59
Amsterdam 52
Turku 48
Santa Clara 38
Brno 34
Helsinki 31
Melbourne 30
New York 24
Milan 22
Naples 22
Tokyo 19
Chicago 17
São Paulo 17
Warsaw 15
West Jordan 14
Burgas 13
Hanover 13
Secaucus 13
Boston 12
Canberra 12
Hasselt 12
St Louis 12
Brooklyn 11
Mexico City 10
Montreal 10
Padova 10
Sona 10
Sydney 10
The Dalles 9
Central 8
Charlotte 8
Dallas 8
Haikou 8
Johannesburg 8
Redmond 8
Campobasso 7
Guangzhou 7
Manchester 7
Vienna 7
Xi'an 7
Baoding 6
Buffalo 6
Chennai 6
Madrid 6
Palermo 6
Paris 6
Stockholm 6
Andover 5
Beijing 5
Haifa 5
Las Vegas 5
Lima 5
Modena 5
New Taipei 5
Oklahoma City 5
Riyadh 5
San Pietro in Lama 5
Teramo 5
Yeonsu-gu 5
Ankara 4
Atlanta 4
Charleston 4
Dublin 4
Florence 4
Frankfurt am Main 4
Istanbul 4
Lincoln 4
Liverpool 4
Markham 4
Monza 4
Phoenix 4
San Ferdinando Di Puglia 4
Sarajevo 4
Shenzhen 4
Shijiazhuang 4
Willisau 4
Wuhan 4
Antwerp 3
Barcelona 3
Budapest 3
Denver 3
Dongguan 3
Durham 3
Falkenstein 3
Ferrara di Monte Baldo 3
Totale 7.610
Salva come PNG Salva come JPEG
Nome #
A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: An open-label, non randomized, pilot study 216
A novel predictive biomarker of immunotherapy response in metastatic renal cell carcinoma (mRCC): The lymphocyte microRNA expression profile. 206
5-Fluorouracil, epirubicin, and BCNU (FEB) in advanced measurable gastric cancer 199
ANGIOGENESIS AND ONCOGENES IN COLON CANCER 199
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 199
COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables 198
Complementary use of local excision and transanal endoscopic microsurgery for rectal cancer after neoadjuvant chemoradiation 194
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 193
Early impairment of food intake in patients newly diagnosed with cancer 193
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung) 193
96P Induction chemotherapy backbone in frail patients (pts) with advanced NSCLC treated with chemotherapy plus pembrolizumab (P): A single institution retrospective audit of dose intensities from modified regimens 190
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 190
Chondrosarcoma of the iliac wing in Von Hippel-Lindau disease 189
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features 188
Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients 188
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 188
Premetastatic niche: ready for new therapeutic interventions? 187
A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation 187
COX-2 expression in lobular in situ neoplasia of the breast: correlation with histopathological grading system according to the Tavassoli classification 185
In Situ Identification of CD44+/CD24− cancer cells in primary human breast carcinomas 184
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 184
Artificial Intelligence in Detection, Management, and Prognosis of Bone Metastasis: A Systematic Review 183
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss 182
Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions 182
Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial 180
Alternative dosing schedules for sunitinib as a treatment of patients with metastatic renal cell carcinoma 178
COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters 177
Enoxiparin effects depend on body-weight and current doses my be inadequate in obese patients 177
Association between NOD2/CARD15 polymorphisms and coronary artery disease: a case-control study 177
Bisphosphonates: new antiangiogenic molecules in cancer treatment? 177
Prevention of radiotherapy-induced emesis 177
[Methodological issues and first results of a record linkage between AIDS and Cancer Registries in Italy 176
Early opioid exposure (EOE) and impaired efficacy in patients with advanced NSCLC treated with PD-L1 inhibition: A pooled post hoc analysis of the POPLAR and OAK trials 175
Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients 175
1065P Dose dependent detrimental effect of baseline pantoprazole on clinical outcomes from first-line chemo-ICI regimens in patients with advanced stage NSCLC 172
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients 168
Gemcitabine-induced atrial fibrillation: A hitherto unreported manifestation of drug toxicity 166
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 164
Complications of therapy in cancer patients: Case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient 162
Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging 162
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 161
Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities 158
Docetaxel induced pericardial effusion 158
A staphylococcus aureus coinfection on a COVID-19 pneumonia in a breast cancer patient 153
Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients 148
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients 134
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 115
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 104
'Internal bracing' surgery in the management of solid tumor metastases of the thoracic and lumbar spine 103
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center Experience 102
A giant sarcoma of the parotid gland: A case report and review of the literature 102
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 100
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome 98
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 96
A close relationship between HIF-1α expression and bone metastases in advanced NSCLC, a retrospective analysis 94
Colorectal carcinomas and PTEN/MMAC1 gene mutations 93
'Old' and 'new' drugs for the treatment of cancer pain 92
Carcinoma of the Ampulla of Vater morphological and immunophenotypical classification predicts overall survival 91
Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect 91
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 90
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 90
Concurrent radiotherapy with palbociclib or ribociclib for metastatic breast cancer patients: preliminary assessment of toxicity 89
[Neoplastic hypercalcemia]. 88
Cerebellar metastasis from pancreatic adenocarcinoma. A case report 87
A pathology-based combined model to identify pam50 non-luminal intrinsic disease in hormone receptor-positive HER2-negative breast cancer 87
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 87
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 87
An increase of CA 19.9 as the first clinical sign of ileocecal valve metastasis from breast cancer 86
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients 86
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 86
How I Treat Localized Soft Tissue Sarcomas: Update on Diagnosis, Risk Stratification, and Treatment 85
A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer 85
An omental mass: any hypothesis? 85
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours 85
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 85
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin 85
Biological effects of cabozantinib on bone microenvironment 85
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 85
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 84
Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial 84
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 83
Idiosyncratic reaction after oxaliplatin infusion 83
A form to report pain assessment and monitoring in the oncology clinical record: a Delphi process 82
Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients 82
In vivo effects of zoledronic acid on peripheral gamma delta T lymphocytes in early breast cancer patients 82
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 82
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 82
Brain microischemic phenomena in a woman receiving bevacizumab treatment: a case report 82
Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review 81
[Aztreonam and oxacillin in the treatment of febrile neutropenic patients with solid tumors]. 81
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 81
Cox-2 Expression in Different Histotypes of Ampullary Carcinoma 81
Atypical chronic head and neck pain: don't forget Eagle's syndrome 81
Liver involvement in the course of thymoma-associated multiorgan autoimmunity: The first histological description 81
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 80
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 80
Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma 80
A Longitudinal Study of Breakthrough Cancer Pain: An Extension of IOPS-MS Study 80
Large abdominal mass in Crohn's disease 79
[Fluorouracil and high-dose folinic acid in the treatment of advanced colorectal carcinoma]. 78
Totale 12.985
Salva come PNG Salva come JPEG
Categoria #
all - tutte 210.935
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 210.935
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022840 0 5 8 11 63 5 6 5 20 22 19 676
2022/2023202 22 7 3 19 9 8 18 18 12 1 76 9
2023/20242.028 46 228 137 146 188 872 21 131 26 67 78 88
2024/202519.054 311 224 782 138 150 473 324 79 1.662 1.533 6.208 7.170
2025/20263 3 0 0 0 0 0 0 0 0 0 0 0
Totale 22.127